IO Biotech (IOBT) Stock Chart & Stock Price History → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free IOBT Stock Alerts $1.50 -0.04 (-2.60%) (As of 04:27 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media IO Biotech Stock Price Performance5 Day Performance+1.35%1 Month Performance-2.60%3 Month Performance-18.92%6 Month Performance+58.16%Year-To-Date Performance-20.21%1 Year Performance-26.83% Receive IOBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IO Biotech and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. IOBT Stock Chart for Wednesday, May, 8, 2024 IOBT Chart by TradingView IO Biotech Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$1.49$1.54+3.36%$1.60$1.4567,465 shs$101.46 million05/06/2024$1.48$1.49+0.68%$1.55$1.4544,626 shs$98.16 million05/03/2024$1.53$1.48-3.27%$1.58$1.4838,646 shs$97.50 million05/02/2024$1.55$1.53-1.29%$1.61$1.5066,090 shs$100.80 million05/01/2024$1.46$1.55+6.16%$1.58$1.42100,209 shs$102.11 million04/30/2024$1.49$1.46-2.01%$1.55$1.4339,407 shs$96.19 million Get the Latest News and Ratings for IOBT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IO Biotech and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$1.42$1.49+4.93%$1.53$1.4546,365 shs$98.16 million04/26/2024$1.45$1.42-2.07%$1.54$1.4073,378 shs$93.55 million04/25/2024$1.46$1.45-0.68%$1.50$1.4247,203 shs$95.53 million04/24/2024$1.47$1.46-0.68%$1.49$1.4357,227 shs$96.19 million04/23/2024$1.44$1.47+2.08%$1.51$1.4258,974 shs$96.84 million04/22/2024$1.48$1.44-2.70%$1.55$1.4178,243 shs$94.87 million04/19/2024$1.47$1.48+0.68%$1.56$1.4291,545 shs$97.50 million04/18/2024$1.50$1.47-2.00%$1.56$1.44178,052 shs$96.85 million04/17/2024$1.54$1.50-2.60%$1.57$1.4636,501 shs$98.82 million04/16/2024$1.52$1.54+1.32%$1.55$1.47100,581 shs$101.46 million04/15/2024$1.55$1.52-1.94%$1.59$1.50133,958 shs$100.14 million04/12/2024$1.60$1.57-1.88%$1.63$1.5366,853 shs$103.43 million04/11/2024$1.58$1.60+1.27%$1.63$1.54118,243 shs$105.41 million04/10/2024$1.58$1.58$1.63$1.55155,464 shs$104.09 million04/09/2024$1.54$1.58+2.60%$1.64$1.5666,190 shs$104.09 million04/08/2024$1.58$1.54-2.53%$1.68$1.5169,708 shs$101.46 million04/05/2024$1.63$1.60-1.84%$1.70$1.55124,187 shs$105.41 million04/04/2024$1.70$1.63-4.12%$1.74$1.58211,371 shs$107.39 million04/03/2024$1.71$1.70-0.58%$1.73$1.6062,976 shs$112.00 million04/02/2024$1.71$1.71$1.74$1.6373,614 shs$112.66 million04/01/2024$1.73$1.71-1.16%$1.75$1.6448,480 shs$112.66 million03/29/2024$1.73$1.73$1.80$1.7053,557 shs$113.97 million03/28/2024$1.73$1.73$1.80$1.7053,556 shs$113.97 million03/27/2024$1.69$1.73+2.67%$1.79$1.67121,187 shs$113.97 million03/26/2024$1.73$1.69-2.60%$1.77$1.6438,132 shs$111.01 million03/25/2024$1.75$1.73-1.14%$1.85$1.6479,259 shs$113.97 million03/22/2024$1.62$1.75+8.02%$1.80$1.63153,519 shs$115.29 million03/21/2024$1.63$1.62-0.61%$1.67$1.5766,533 shs$106.73 million03/20/2024$1.63$1.63$1.66$1.58138,659 shs$107.38 million03/19/2024$1.58$1.63+3.16%$1.63$1.5915,939 shs$107.39 million03/18/2024$1.65$1.58-4.24%$1.69$1.5276,244 shs$104.09 million03/15/2024$1.70$1.65-2.94%$1.77$1.6425,478 shs$108.70 million03/14/2024$1.75$1.70-2.86%$1.79$1.6465,342 shs$112.00 million03/13/2024$1.75$1.75$1.85$1.72113,813 shs$115.29 millionCould this Tiny Biotech End Disease Forever? (Ad)Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.Access my full "Cut & Paste" profit analysis now.03/12/2024$1.78$1.75-1.69%$1.85$1.7161,204 shs$115.29 million03/11/2024$1.82$1.78-2.20%$1.84$1.7134,927 shs$117.27 million03/08/2024$1.77$1.82+2.82%$1.84$1.7145,071 shs$119.90 million03/07/2024$1.66$1.77+6.63%$1.78$1.6843,215 shs$116.61 million03/06/2024$1.62$1.66+2.47%$1.72$1.5142,723 shs$109.36 million03/05/2024$1.68$1.62-3.57%$1.68$1.6026,431 shs$106.73 million03/04/2024$1.76$1.68-4.55%$1.80$1.5949,883 shs$110.68 million03/01/2024$1.60$1.76+10.00%$1.85$1.59483,762 shs$115.95 million02/29/2024$1.53$1.60+4.58%$1.63$1.48143,628 shs$105.41 million02/28/2024$1.59$1.53-3.77%$1.64$1.51117,039 shs$100.80 million02/27/2024$1.55$1.59+2.58%$1.65$1.52173,764 shs$104.75 million02/26/2024$1.51$1.55+2.65%$1.60$1.4893,017 shs$102.11 million02/23/2024$1.48$1.51+2.03%$1.60$1.4839,867 shs$99.48 million02/22/2024$1.53$1.48-3.27%$1.58$1.4870,002 shs$97.50 million02/21/2024$1.54$1.53-0.65%$1.56$1.45142,149 shs$100.80 million02/20/2024$1.59$1.54-3.14%$1.62$1.5386,198 shs$101.46 million02/19/2024$1.59$1.59$1.70$1.48138,700 shs$104.75 million02/16/2024$1.52$1.59+4.61%$1.70$1.48138,656 shs$104.75 million02/15/2024$1.61$1.52-5.59%$1.66$1.51212,085 shs$100.14 million02/14/2024$1.66$1.61-3.01%$1.74$1.552.17 million shs$106.07 million02/13/2024$1.69$1.66-1.78%$1.75$1.62170,330 shs$109.36 million02/12/2024$1.63$1.69+3.68%$1.79$1.6558,149 shs$111.34 million02/09/2024$1.85$1.63-11.89%$1.89$1.50981,085 shs$107.38 million02/08/2024$1.79$1.85+3.35%$1.89$1.7884,282 shs$121.88 million02/07/2024$1.80$1.79-0.56%$1.84$1.7436,634 shs$117.93 million Related Companies: Anixa Biosciences Stock Chart DiaMedica Therapeutics Stock Chart Clearside Biomedical Stock Chart Oramed Pharmaceuticals Stock Chart Emergent BioSolutions Stock Chart BioXcel Therapeutics Stock Chart Allakos Stock Chart Cellectar Biosciences Stock Chart Adagene Stock Chart PMV Pharmaceuticals Stock Chart Receive IOBT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for IO Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IOBT) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarningsWatch this FREE trading tutorial while it’s still availableInvestorPlace[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IO Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.